PRP guidelines · International

Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial

Christos Thanasas, George Papadimitriou, Charalambos Charalambidis, Ilias Paraskevopoulos, Athanasios Papanikolaou

The American Journal of Sports Medicine · 2011

In brief

A small randomised controlled trial compared ultrasound-guided platelet-rich plasma (PRP) with autologous whole blood for chronic lateral elbow epicondylitis, with an eccentric exercise programme for everyone. The authors report that PRP eased pain more, though the difference was clear only in the early weeks, and that details such as dosing and timing still need defining.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial Authors: Christos Thanasas, George Papadimitriou, Charalambos Charalambidis, Ilias Paraskevopoulos, Athanasios Papanikolaou Link: https://www.ncbi.nlm.nih.gov/pubmed/21813443 Year of Publication: 2011

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.